Beslan Nuralievich Gurmikov

Beslan Nuralievich Gurmikov

Auto-generated profile, based on publicly available information

Beslan Nuralievich Gurmikov

A.V. Vishnevsky National Medical Research Center of Surgery

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Surgical Oncology
Verified
Journal Article
Open access
YKYury Alexeevich Kovalenko
Yury Alexeevich Kovalenko
YZYury Zharikov
Yury Zharikov
NKNatalia Alexeevna Konchina
Natalia Alexeevna Konchina
BGBeslan Nuralievich Gurmikov
Beslan Nuralievich Gurmikov
LMLudmila Anatolievna Marinova
Ludmila Anatolievna Marinova
AZAlexey Vladimirovich Zhao
Alexey Vladimirovich Zhao
Long-term outcomes depend heavily on the possibility of performing radical resection. To evaluate long-term results in perihilar cholangiocarcinoma (PHC) patients from the perspective of a new understanding of radical resection. Consecutive PHC patients who underwent surgical resection at A.V. Vishnevsky Center of Surgery from 2011 to 2018 were retrospectively reviewed. Fifty eight (87.9%) patients underwent hemihepatectomy (14 extended hemihepatectomies), while 2 (3%) underwent extrahepatic bile duct resection only, 6 (9.1%) underwent S4b, and 5 underwent en bloc resection of the extrahepatic bile duct. The influence of the bile duct wedge R status, nodal status, microvascular invasion, microlymphatic invasion, perineural invasion, liver invasion, and surrounding adipose tissue invasion on survival was tested by Cox's models. Survival rates depending on pathological parameter numbers were compared by log-rank tests. Wedge resection, nodal status, microvascular invasion, microlymphatic invasion, perineural invasion, liver invasion, and surrounding adipose tissue invasion served as extended criteria for curability (R+, 1 to 7 parameters). For R0 resection status and R1 resection status (R+1, R+2), 7 and 5 parameters were negative, respectively. For R1+ resection status (R+3, R+4, R+5, R+6, R+7), 3 to 7 parameters were positive. Patients who underwent R0 and R1 resections had 5-year survival rates of 100%; the 1- 2- 3-year survival rates were 63%, 49%, 33% for patients who underwent R1+ resections, respectively. The expanded criteria for determining radical resection levels correlated with long-term outcomes (р = 0.0001). The new concept for radical resection can accurately reflect surgical treatment results and contribute to selecting appropriate adjuvant therapies in PHC patients. The study was carried out in accordance with the framework of the "Multimodal treatment of primary and secondary malignant tumors of the liver and pancreas" (state registration № 315030310062).

15 July 2024 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
ARA.SH. Revishvili
A.SH. Revishvili
VOV.E. Olovyanny
V.E. Olovyanny
PMP.V. Markov
P.V. Markov
BGB.N. Gurmikov
B.N. Gurmikov
AKA.V. Kuznetsov
A.V. Kuznetsov
Objective. To analyze potentially preventable causes of mortality from acute calculous cholecystitis (ACC) at the population level. Material and methods. A retrospective study of causes of ACC-related mortality was conducted. We used online survey of state hospitals and estimated fatal outcomes following ACC considering appropriate annual e-database. Results. There were 1.500 deaths among 142.975 patients aged ≥18 years with acute cholecystitis. We received responses to the proposed questionnaire about 1154 deaths (76.9%). Analysis included 648 cases of ACC (K80.0). Mean age of patients was 76.0 years (31—100). There were 256 (39.5%) men and 392 (60.5%) women. ACC severity was assessed according to the Tokyo guidelines (2018). Mild (I) degree was noted in 24 (3.7%) cases, moderate (II) — 270 (41.7%), severe (III) — 354 (54.6%) patients. Cardiovascular diseases and complications caused death in mild ACC regardless of treatment method in 16 (66.7%) cases, in moderate ACC — 106 (39.3%), in severe ACC — 97 (27.4%) cases. ACC caused death in 3 (12.5%) patients with mild disease, 111 (41.1%) with moderate disease and 200 (56.5%) ones with severe disease. Postoperative complications caused death in 4 (16.7%) patients with mild disease, 29 (10.7%) ones with moderate disease and 30 (8.5%) patients with severe disease. Other causes comprised 4.1% (n=1), 8.9% (n=24) and 7.6% (n=27), respectively. Potentially preventable causes of death were identified in 33.0% of cases. Conclusion. ACC-related mortality is mainly associated with comorbidity in elderly and senile patients, late presentation and complicated course of disease. Delayed surgical treatment due to diagnostic and tactical problems, as well as technical intraoperative errors is potentially preventable causes of death.

15 January 2019 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
BGB. N. Gurmikov
B. N. Gurmikov
YKYu. A. Kovalenko
Yu. A. Kovalenko
VVV. A. Vishnevsky
V. A. Vishnevsky
ACA. V. Chzhao
A. V. Chzhao
The modern concept of therapy for intrahepatic cholangiocarcinoma including surgical treatment, must take into account the achievements of molecular biology and modern staging principles. A detailed understanding of the molecular genetic (genetic and epigenetic) disorders underlying the pathogenesis of cholangiocarcinoma is important, which will improve the results of surgical treatment and expand the possibilities of personalized (targeted) therapy. Based on new data on cholangiocarcinogenesis, molecular profiling of bile duct tumors may be most appropriate for the selection of treatment in cases refractory to standard therapy. Current potential target therapy targets include endothelial growth factor receptors, fibroblast growth factor, MET tyrosine kinase, PI3K/Akt/mTOR signaling pathway and isocitrate dehydrogenase mutation. The review considers the molecular-genetic aspects underlying the pathogenesis and modern principles of staging intrahepatic cholangiocarcinoma.

1 January 2017 in Kuban Scientific Medical Bulletin
Verified
Journal Article
Open access
PDF file
BGB. N. Gurmikov
B. N. Gurmikov
MBM. S. Bolokov
M. S. Bolokov
NGN. L. Gurmikova
N. L. Gurmikova
В последние десятилетия отмечаются тенденция к росту и достаточно высокие показатели заболеваемости раком поджелудочной железы. Отдаленные результаты хирургического лечения остаются неудовлетворительными. Однако, учитывая прогресс медицинских технологий и разработку новых хирургических подходов лечения рака поджелудочной железы, интерес представляет современное состояние этой проблемы. Данный обзор литературы посвящен проблеме отдаленных исходов хирургического лечения у пациентов с раком поджелудочной железы.

15 December 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
KAKh. A. Ayvazyan
Kh. A. Ayvazyan
BGB. N. Gurmikov
B. N. Gurmikov
RAR. O. Anvari
R. O. Anvari
YSYu. A. Stepanova
Yu. A. Stepanova
Dmitry V KalininDmitry V Kalinin
Dmitry V Kalinin
AZA. V. Zhao
A. V. Zhao
Cholangioblastic variant of intrahepatic cholangiocarcinoma is a rare, extremely malignant liver tumor. Currently, only six clinical cases have been described worldwide. Following the bibliographic research, the authors of the paper introduced main features of the tumor, methods of its diagnosis and treatment. A clinical observation of a patient with cholangioblastic variant of intrahepatic cholangiocarcinoma is presented. The course of the disease was complicated by tumor thrombosis of the left hepatic and inferior vena cava with thrombus flotation in the right atrium. The paper describes the stages of the disease diagnosis and surgical treatment of the patient, providing insight into the patient surveillance in such cases. Given the low incidence of such neoplasms, each clinical case reported in the scientific literature is of great value and practical interest.

23 April 2023 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
LML.A. Marinova
L.A. Marinova
ALA.I. Leonova
A.I. Leonova
VDV.A. Demyatova
V.A. Demyatova
BGB.N. Gurmikov
B.N. Gurmikov
AZA.V. Zhao
A.V. Zhao
Mirizzi syndrome is a complication of cholelithiasis occurring in 0.25—6% of cases [1]. Clinical pattern includes jaundice due to prolapse of a large calculus into the common bile duct following cholecystocholedochal fistula. Ultrasound, CT, MRI, MRCP data, as well as some pathognomonic signs provide preoperative diagnostics of Mirizzi syndrome. In most cases, treatment of this syndrome requires open surgery. We report successful endoscopic treatment of a patient with long-standing bile stone disease complicated by Mirizzi syndrome. Postoperative complications of surgery performed in acute period of disease and further staged treatment using retrograde access are illustrated. Endoscopic treatment demonstrated minimally invasive management of disease presenting diagnostic and technical difficulties.